Heterogeneity of response and survival in diffuse histiocytic lymphoma after BACOP therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples